00078-0690 Arzerra - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00078-0690

Brand Name:

Arzerra

Generic Name:

Ofatumumab

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Substances:

Name: Ofatumumab

Strength: 20.0

Unit: mg/mL

Packages:

Code: 00078-0690-61

Description: 50 mL in 1 VIAL, SINGLE-USE (0078-0690-61)

Effective Date: Feb. 1, 2016

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

CD20

Orphan Drug Designation:

Status:

In Use